通过WGCNA分析和机器学习识别与cuproptosis相关的喘诊断基因
Fangwei Wang1, Qisheng Su2, Chaoqian Li1
1Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nan'ning, China.
概括
细胞亡是一种新型的细胞死亡形式,与喘有关. 研究人员确定了五个关键基因 (TRIM25,DYSF,NCF4,ABTB1,CXCR1) 作为喘诊断和预后的潜在生物标志物.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 质亡是一种新兴的调节细胞死亡形式.
- cuproptosis 和喘病原体之间的确切关系尚不清楚.
研究的目的:
- 为了研究喘中与cuproptosis相关的基因的作用.
- 为了确定潜在的生物标志物用于喘诊断和预后.
主要方法:
- 从GEO数据库中对与cuproptosis相关的基因的差异基因表达分析.
- 免疫透分析和KEGG通路分析.
- 通过WGCNA,机器学习模型 (XGB,SVM,RF,GLM) 和体外验证.
主要成果:
- 确定了六个与cuproptosis相关的基因,并与各种生物功能联系在一起.
- 喘患者被分为两种亚型,具有不同的免疫特征.
- 一个五个基因的签名 (TRIM25,DYSF,NCF4,ABTB1,CXCR1) 证明了高的诊断效率喘生存概率.
结论:
- 这项研究突出显示了cuproptosis在喘中的作用.
- 确定了与cuproptosis相关的基因和五个基因签名,为喘提供了潜在的诊断和预后价值.
- 为进一步研究喘的分子机制提供了基础.
相关概念视频
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


